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ABSTRACT 
Andrographis paniculata (Burm.f.) Wall. Ex. Nees (A. Paniculata), i.e. Kalmegha is a medicinal plant traditionally used for various 
diseases such as fever, diarrhea, worm infestation, hepatic and skin diseases. Modern studies have also explicitly revealed that A. 
Paniculata has a wide range of pharmacological effects such as anti-inflammatory, anti-hyperglycemic, anti-diarrhoeal, anti-viral, 
anti-malarial, hepato-protective, anti-cancer, anti-human immunodeficiency virus (HIV), and also work as an immune stimulator. On 
the other hand, Gout (Vatarakta) is one common metabolic disorder which affects over 1% of the world’s adult population.  
Objective: To assess the clinical efficacy of A. Paniculata in Gouty Arthritis.  
Study Design: A clinical research, prospective in style, wherein a hypothesis, based on the previous studies on the various effects of 
A. Paniculata, was made; to assess its efficacy in treating Gout.  
Methodology: Randomly selected patients (n = 31) were administered powder of A. Paniculata, 2 gms thrice daily with water, for 45 
days with a follow-up in every 15 days for one month. Assessment of the treatment was based on before treatment (BT) and after 
treatment (AT) effects of A. Paniculata on the parameters namely; subjective, i.e. the symptoms of Gout and objective, i.e. the levels 
of Serum Uric Acid.  
Results: In subjective parameters, Wilcoxon non-parametric test was used. The outcome shows that except the symptom i.e. Pallor 
(shwetata), in all other symptoms of Gout, p value was either < 0.05 or < 0.01, which is considered to be significant to highly 
significant. In objective parameter, Z test was used, in which the outcome of p value was < 0.01, which indicates that the effect of A. 
Paniculata on Serum Uric Acid is highly significant.  
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With an increase in the erratic ways of dietary and life-style 
habits, we are witnessing an ever growing menace of 
several metabolic disorders. Gouty arthritis is one of them 
affecting over 1% of the world’s adult population. 1 Modern 
aspect defines gout as a hereditary metabolic disease that 
is a form of acute arthritis and is marked by inflammation 
of the joints with the etiology of excessive uric acid in the 
blood (hyperuricemia) and deposits of urates of sodium in 
and around joints. Several different metabolic 
abnormalities may also cause hyperuricemia. 2 
Gout is a disease of antiquity. Considering the symptoms 
and pathogenesis, Gout can be co-related with Vatarakta in 
Ayurvedic sciences. Some common symptoms of Vatarakta 
include; Kandu (Itching), Daha (Burning sensation), Ruja 
(Pain), Sira-ayama (Dilatation of the vessels), Toda 
(Pricking pain), Sphurana (Trembling or throbbing 
sensation), Sira-akunchana (Contraction), Shyav-twak 
(Cyanosis of skin), Rakta-twak (Reddish coloration of skin), 
Bheda (Splitting type of pain), Gourava (Heaviness), 
Suptata (Numbness), etc. 3 
Modern Drugs used to treat acute attacks and prevent 
future attacks of Gout includes: Non-steroidal anti-
inflammatory drugs (NSAIDs), Colchicine and 
Corticosteroids, etc. Owing to the rise in awareness about 
the disease, its treatments and undesirable possible 
adverse effects of modern drugs, more and more people 
are opting for a safe and cost effective treatment options. In 
the past few years, there is growing an interest in 
Ayurveda, especially in the herbal sector, worldwide.  
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Kalmegha (Andrographis paniculata (Burm.f.) Wall.ex 
Nees), Family – Acanthaceae, a common herb, used 
extensively in liver disorders and is a potent blood purifier 
is found throughout the planes of India, Pakistan, Sri Lanka 
and West Indies. 4 
Kalmegha is commonly known as Bhunimba, Yavatikta and 
Desi chirayata. According to Ayurvedic texts, Kalmegha is a 
herb with Tikta rasa, Katu vipaka, Laghu–Ruksha Guna, and 
Ushna Veerya and due to these attributes it performs 
various therapeutical actions such as Vishodhan 
(purificatory), Tridosha-shaman (helps balancing Tri-
doshas), Shothaghna (edema) and Udar-Rog Nashak 
(gastro-intestinal disorders)5, Kapha-Pitta shamana 
(pacifies Kapha-Pitta), Deepan (appetizer), Swedan 
(diaphoretic), Jwaraghna (anti-pyretic), Kriminashak (anti-
helminthic) and Kushthaghna (skin diseases) 7. It is a very 
effective Katu-paushtik (bitter yet nourishing), and Yakrit-
rog Nashak (hepatoprotective) drug.6 Modern studies have 
also explicitly revealed that A.Paniculata has a wide range 
of pharmacological effects and some of them extremely 
beneficial such as anti-hyperglycemic (Bu-Chin et al., 2003) 
8, anti-diarrhoeal (Gupta et al.,1990; Gupta et al.,1993) 9, 10, 
anti-viral (Wiart et al., 2005) 11, anti-malarial (Mishra et 
al.,1992) 12, hepato-protective (Clander et al., 1995) 13, anti-
cancer (Cheung et al., 2005) 14, anti-human 
immunodeficiency virus (HIV) (Calabrese et al., 2000) 15, 
and also work as an immune stimulator (Puri et al., 1993) 
16. 
MATERIAL AND METHODS 
A clinical study, made to observe the effect of Kalmegha (A. 
paniculata) in Vatarakta (Gout), was approved by the 
Research Development Committee (RDC) of Uttarakhand 
Ayurved University, Harrawala, Dehradun on July 28th, 
2016.  
1) Source of the drug:   
The plant material, A. Paniculata, whole plant, used in the 
clinical study was procured from a reliable source of 
Dehradun market. Its authentication was done in the PG 
Department, DravyaGuna, UAC, Dehradun.   
2) Identity, Purity and Strength:   
At the same time, the whole plant of A.Paniculata was 
collected from the Non Wood Forest Products (NWFP) 
Division, Forest Research Institute (FRI), Dehradun and a 
herbarium specimen was made and deposited at the 
Systematic Botany Branch (SBB), FRI, Dehradun. The plant 
was authenticated and an Herb Registration Number – 
172435, dated November 17th, 2017 was assigned to it. 
This plant sample was set as standard.   
Thin layer chromatography (TLC) technique was used to 
ascertain the identity and quality of the commercially 
available plant material through comparison of its TLC 
profile with that of the authenticated plant material used as 
standard. Results of the comparative TLC revealed that 
both the samples were qualitatively alike. 
3) Preparation of drug for the clinical trial:  A total of 15 
kgs of commercially available plant material of A.Paniculata 
was purchased and after cleaning, washing and shade 
drying, it was milled and a fine powder of 35 mesh size 
from a normal sieve was prepared.  
4) Dosage and Duration of treatment: Dosage of 2 gms of 
A.Paniculata powder thrice daily to be taken with water 
was prescribed.  
5) Number of patients: Total 43 patients were registered 
for the studies from the OPD of Uttaranchal Ayurvedic 
Hospital, Dehradun during the month of August 2017. 
6) Follow-up: After the completion of 45 days treatment, a 
follow-up was done for one month in every 15 days to 
ascertain the adverse effects of the treatment if any. Out of 
43 cases registered for the study, 31 cases turned up for 
full follow-ups.  
7) Inclusion Criteria:   
 Randomly selected patients within the age group of 
20-60 years irrespective of sex, cast, religion, 
economic status.  
 Patients having common clinical features of Vatarakta 
as described in Ayurveda, namely; oedema (shvyathu), 
stiffness (stabdhata), inflammation (shotha), itching 
(kandu), heaviness (guruta),  numbness (suptata) and 
piercing pain (toda) in knees, shanks, thighs, waist, 
shoulder, hands, feet and joints of the body. And 
fatigue (shram), pallor (shwetata), thirst (trishna) and 
indigestion (ajirna). 
 Diagnosed patient of Vatrakta (Gout).  
 Patients having serum uric acid level 5.5 to 10.0 
mg/dl.   
8) Exclusion Criteria:  
 Patients with Chronic Debilitating Diseases.  
 Patients having Cardio Vascular Disease.  
 Patients below 20 years and above 60 years.  
 Patients suffering from any Infectious Disease.  
 Diagnosed cases of Thyroid abnormalities.  
 Patients of CRF and Hepatic disorders.  
 Immuno-compromised patients.  
 Patients of Gout associated with any severe arthritis 
condition like acute rheumatoid arthritis, crooked 
fingers (anguli-vakrata), mental confusion (moha) and 
tumor like hard swelling (arbud) will be excluded from 
the study.   
9) Assessment Criteria:  The assessment criteria of the 
clinical studies were both subjective and objective.   
a) Subjective (symptoms based):   
 Oedema (shvyathu)  
 Stiffness (stabdhata)   
 Inflammation (shotha)   
 Itching (kandu)  
 Heaviness (guruta)    
 Numbness (suptata)  
 Piercing pain (toda)   
 Fatigue (shram)  
 Pallor (shwetata)   
 Thirst (trishna)  
 Indigestion (ajirna)   
b) Objective:   
 Serum Uric Acid   
10) Pathyapathya (diet and life-style guidelines):  
Pathya and Apathya in terms of diet and life-style 
guidelines were prescribed as mentioned in Ayurvedic 
texts.  
 
 Do’s (Pathya Aahar- Vihaar): Light and easy to digest 
food, barley (puranyava), wheat (godhuma), shali rice, 
flesh broth of gallinaceous birds (vishikar mansras), 
pigeon pea (arhardaal), bathua, bengal gram (chana), 
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petha, moongdaal, red lentil (masoordaal), bitter 
gourd (karela), pointed gourd (parwal), amla, raisins 
(munakka and kishmish), black night-shade (makoya), 
milk and pure ghee. Oil massages (abhyanga), poultice 
(upnaha), pradeha and parishek.  
 Don’ts (Apathya Aahar-Vihaar): Katu rasa (pungent), 
food which causes heating effect and is heavy to digest, 
fried, spicy, sour (amla) and salty (lavan) food items, 
curd and its products, sesame (til) and its products, 
black gram (udad), horse gram (kulath), alcohol, beans 
(sem) and radish. Diurnal sleep (diwaswap), sun 
bathing (aatap-sewan), excessive exercise and over 
indulgence in sexual activities.    
 
 
OBSERVATIONS AND RESULTS 
a) Subjective (symptoms based): Wilcoxon non-
parametric test was used to analyze the effect of 
A.Paniculata on the various symptoms of Vatarakta (Gout) 
in different patients under study. The positive and negative 
ranks based upon the patient’s response along with the 
Wilcoxon statistics are shown in the Table 1. The p-value 
mentioned in this table is for two tailed test and at 5% level 
of significance. The meaning of nature of the rank is as: 
Negative Ranks – Grade is decreasing i.e. improvement in 
the symptom after treatment.  
Positive Ranks – Grade is increasing i.e. deterioration in the 
symptom after treatment.  
Ties – No difference in the grades i.e. no change or relief in 
the symptom after treatment.   
The results were analyzed by the Statistical software SPSS 
(version 16). 
Table 1: Ranks Due to Wilcoxon Non parametric test 
Symptom Ranks % Improvement Wilcoxon Statistic p value 
Negative Positive Ties 
Edema 15 0 16 48.35% - 3.771 < 0.01 
Stiffness 21 0 10 67.74% - 4.491 < 0.01 
Inflammation 9 0 22 29.03% - 3.000 < 0.01 
Itching 4 0 27 12.90% - 2.000 < 0.05 
Heaviness 13 0 18 41.94% - 3.606 < 0.01 
Numbness 6 0 25 19.35% - 2.449 < 0.05 
Piercing pain 26 0 5 83.87% - 4.874 < 0.01 
Fatigue 7 0 24 22.58% - 2.646 < 0.01 
Pallor 0 0 31 0% 0.000 > 0.05 
Thirst 5 0 26 16.13% - 2.236 < 0.05 
Indigestion 22 0 9 70.97% - 4.690 < 0.01 
 
The outcome in the above table indicates that out of 11 
symptoms assessed, in 7 symptoms namely, edema 
(shvyathu), stiffness (stabdhata), inflammation (shotha), 
heaviness (guruta), piercing pain (toda), fatigue (shram), 
and indigestion (ajirna), p value obtained was less than < 
0.01 which is considered to be highly significant at 5% level 
of significance. In 3 symptoms namely, itching (kandu), 
numbness (suptata) and thirst (trishna), p value was found 
to be less than < 0.05 which is considered to be significant 
at 5% level of significance. It was only the symptom pallor 
(shwetata) which showed the p value > 0.05, which means 
that A.Paniculata shows no effect on pallor (shwetata) 
symptom of Vatarakta (Gout). 
b) Objective: Z Test was used to see the significant effect, if 
any, of A. Paniculata on the levels of Serum Uric Acid based 
upon 31 observations under study. 
   
Table 2: Effect on BT and AT of Kalmegha (A. Paniculata) on Uric Acid: Descriptive Statistics and paired Z test for 
significance 







BT 6.73 (±0.11) 0.713 (<0.01) 0.655 (0.445) 




Above table shows that the average values of Serum Uric 
Acid for BT is 6.73 ± 0.110 (mean ± SEM) and the same is 
6.07 ± 0.10 for the AT. The sample correlation coefficient 
between BT and AT is found to be 0.713 which is highly 
significant at 1% level of significance as p value is less than 
0.01. In addition, mean difference of Uric Acid was 0.655 
mg/dl. The lower and upper bounds of this difference were 
found to be 0.492 mg/dl and 0.818 mg/dl respectively.  
It shows that there is a significant difference between BT 
and AT of A. paniculata on Serum Uric Acid.  
DISCUSSION 
In both subjective and objective parameters, as mentioned 
above, a significant difference was found between BT and 
AT of using A. Paniculata. There is a marked improvement 
in the symptom indigestion (ajirna) shown by 70.97% of 
the patients. It could be because of the Tikta Rasa, Laghu 
Guna and Katu Vipaka of A. Paniculata, all of which acts as 
laghav karma in the body. Appetite, flatulence, acidity and 
bowel movements becomes better, which further leads to 
the improvement of other symptoms such as heaviness 
(guruta) and fatigue (shram). This once again proves the 
efficacy of A. paniculata on the proper functioning of liver 
enzymes. And the synonym “Udarnashini” of Dhanwantari 
Nighantu [5] is justified. 67.74% of the patients showed 
improvement in the stiffness (stabdhata), while 29.03% of 
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the patients got significant results in inflammation 
(shotha). This could be because of the Kapha pitta shamaka 
action of A. paniculata. Edema (shvyathu) also gets 
improved in 48.35% of the patients because of the Ruksha 
property and Ushna Veerya of A. paniculata.   
It is interesting to note that except for one patient, the 
Serum Uric Acid levels of the remaining 30 patients 
showed good improvement. This fact again confirms the 
already established blood purifying properties of A. 
Paniculata. And hence piercing pain (toda), which was 
present in every patient, got highly significant results with 
83.87% of patients reported to have marked improvement.   
Couple of patients (age > 55 years) gave no response in any 
of the subjective and objective parameters. It could be 
because of their already sluggish metabolism, due to 
chronicity and age factor. However, many patients in this 
age bracket responded well with the recent symptoms of 
pain in smaller joints.   
There were no adverse or undesirable side effects noted, in 
terms of clinical presentation or lab investigation, post 
studies. It is important to note that Pathya-Apathya plays 
an important role in curing the disease. The patients, who 
followed the prescribed diet and life-style guidelines 
diligently, responded well and took less time to recover.   
There were some other notable benefits too. One patient in 
the study was suffering from pitting nails, reported to have 
complete relief in this condition, after 45 days of the 
treatment. Another patient of psoriasis reported 
regression in the symptoms of psoriasis as well. 
CONCLUSION 
The present study illustrates that the overall effect of 
A.paniculata, with its Rasa, Guna, Veerya, Vipaka and 
Karma, corrects the metabolism and purifies the blood, 
eventually helping in disintegrating the pathogenesis 
(samprapti-vighatan) of Vatarakta (Gout). A. paniculata, is 
a potent medicinal plant with high adaptive qualities. With 
its varied usage in Kushta, Kandu, Shvyathu, Yakratroga, 
Krimi, Kushta, Jwara, etc, and with the highly encouraging 
results on Vatarakta as illustrated in the present study, it’s 
one of the synonym i.e. Yashaskari - means that brings Yash 
(success and fame) to the physician is well established. 
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